Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T8AJ
|
||||
| Former ID |
DNC009659
|
||||
| Drug Name |
N-(biphenyl-3-yl)-6-(sulfamoylamino)hexanamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529866] | ||
| Formula |
C18H23N3O3S
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCNS(=O)(=O)N
|
||||
| InChI |
1S/C18H23N3O3S/c19-25(23,24)20-13-6-2-5-12-18(22)21-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,20H,2,5-6,12-13H2,(H,21,22)(H2,19,23,24)
|
||||
| InChIKey |
XZBFBJMQHOJIMB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase 6 | Target Info | Inhibitor | [529866] | |
| KEGG Pathway | Alcoholism | ||||
| Viral carcinogenesis | |||||
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
| Signaling events mediated by HDAC Class I | |||||
| References | |||||